The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.

Name:	us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- References

No definition available.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Cash flows from operating activities:
Net loss	$ (14,433,881)	$ (15,046,132)	$ (14,079,927)	$ (14,307,829)	$ (29,480,012)	$ (28,387,756)
Adjustment to reconcile to net loss to net cash used in operating activities:
Depreciation and amortization expense	84,527		90,533		169,788	180,742
Reduction in carrying amount of right-of-use assets					168,386	167,787
Intangible asset amortization	7,317		7,317		14,633	14,633
Stock-based compensation expense					3,217,210	3,136,507
Net accretion of discount on marketable securities					0	(169,351)
(Increase) decrease in:
Prepaid expenses and other current assets					2,072,921	(539,236)
Other assets					454,058	(193,644)
Increase (decrease) in:
Accounts payable					500,679	510,570
Accrued expenses					(458,170)	(1,416,812)
Lease liabilities					(162,298)	(150,946)
Other liabilities					(23,957)	(169,528)
Net cash used in operating activities					(23,526,762)	(27,017,034)
Cash flows from investing activities:
Purchases of property and equipment					(11,061)	(70,251)
Maturities of marketable securities					0	26,430,000
Net cash (used in) provided by investing activities					(11,061)	26,359,749
Cash flows from financing activities:
Proceeds from exercise of stock options					2,055	732,458
Proceeds from issuance of common stock under employee stock purchase plan					133,892	247,465
Proceeds from issuance of common stock under at-the-market offering, net of offering expenses					13,676,667	0
Payment of offering costs					(64,013)	0
Net cash provided by financing activities					13,748,601	979,923
Net (decrease) increase in cash and cash equivalents					(9,789,222)	322,638
Cash and cash equivalents at beginning of period		$ 36,144,720		$ 59,405,817	36,144,720	59,405,817	$ 59,405,817
Cash and cash equivalents at end of period	$ 26,355,498		$ 59,728,455		$ 26,355,498	$ 59,728,455	$ 36,144,720